MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0028070
Exsiva Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.55 Cr
▲ 14% YoY
Net profit · FY 2025
₹31.69 Lakh
Net margin 5.7%
EBITDA · FY 2025
₹61.86 Lakh
EBITDA margin 11.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
6
Provident fund records
About Exsiva Pharma Private Limited
Data last updated:
Exsiva Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2016PTC126382. Its GSTIN is 18AAECE2652H1ZP (Assam). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Darpana Baruah and Aminul Haque Choudhury.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 28 Pnr Meadows D. Pochampally Qutubullapur Mandal Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.55 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹31.69 Lakh (net margin 5.7%) and EBITDA of ₹61.86 Lakh (EBITDA margin 11.1%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 23% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1 Cr on record.
Exsiva Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0028070). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website exsivapharma.in.
Company details
CIN U74999TG2016PTC126382
Registration Number 126382
Incorporation Date 16 May 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0028070
CIN history
Exsiva Pharma has one previous CIN (Corporate Identification Number): U74999AS2016PTC017415. The current CIN is U74999TG2016PTC126382, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999TG2016PTC126382 | Current |
| U74999AS2016PTC017415 | Previous |
Recognitions & Rankings of Exsiva Pharma
Contact details
Exsiva Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is exsivapharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo. 28 Pnr Meadows D. Pochampally Qutubullapur Mandal Hyderabad, Telangana, India – 500055
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Exsiva Pharma Private Limited, buy the company report.
Comprehensive company report
Exsiva Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Exsiva Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Exsiva Pharma Private Limited, buy the company report.
Financials of Exsiva Pharma Private Limited
FY 2025 filings availableExsiva Pharma Private Limited reported revenue of ₹5.55 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹5.55 Cr ▲ 14%
Net profit · FY 2025
₹31.69 Lakh margin 5.7%
EBITDA · FY 2025
₹61.86 Lakh margin 11.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 38%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 51%
5 years · compounded
▲ 34%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 14% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.1% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Exsiva Pharma Private Limited, buy the company report.
Board of directors of Exsiva Pharma Private Limited
Exsiva Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Darpana Baruah | Director | 16 May 2016 | 10 Years 5 Months | Current |
| Aminul Haque Choudhury | Director | 16 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Exsiva Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| HDJ Telecom Private Limited | ₹5.56 Cr (FY 2025) | 17.0% | Shillong, Meghalaya, India | |||
| Viraneka Enterprises Private Limited | ₹5.56 Cr (FY 2024) | -57.0% | Thiruvananthapuram, Kerala, India | |||
| Premium Air Care Solutions Private Limited | ₹5.55 Cr (FY 2025) | 5.0% | Bhubaneswar, Odisha, India | |||
| Kamalkant Vinimay Private Limited | ₹5.55 Cr (FY 2016) | -49.0% | Kolkata, West Bengal, India | |||
| R.R.R. Pharma Private Limited | ₹5.55 Cr (FY 2025) | 9.0% | Chennai, Tamil Nadu, India | |||
| Exsiva Pharma Private Limitedthis company | ₹5.55 Cr (FY 2025) | ₹31.69 Lakh | 5.7% | 14.0% | 6 | Hyderabad, Telangana, India |
| Studiomas Hosiery India Private Limited | ₹5.55 Cr (FY 2024) | 476.0% | Coimbatore, Tamil Nadu, India | |||
| Safeworld Systems Private Limited | ₹5.55 Cr (FY 2025) | -22.0% | Ahmedabad, Gujarat, India | |||
| Kishori Lal Marketing Private Limited | ₹5.55 Cr (FY 2024) | -9.0% | Punjab, India | |||
| Edura Pharmaceuticals Private Limited | ₹5.55 Cr (FY 2025) | -14.0% | New Delhi, Delhi, India | |||
| Ravel Hiteks Private Limited | ₹5.55 Cr (FY 2024) | 11.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Exsiva Pharma Private Limited, buy the company report.
Auditor
Exsiva Pharma Private Limited is audited by Hari Singh & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Hari Singh & Associates | FY 2023 | 323509E |
Shareholding
The shareholding of Exsiva Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Exsiva Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Nov 2025 | 101193770 | Uco Bank | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Exsiva Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Exsiva Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Exsiva Pharma Private Limited has a workforce of 6 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
6
Active EPFO establishments
1
Employee growth
-40%
GST
Exsiva Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AAECE2652H1ZP | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Exsiva Pharma Private Limited, buy the company report.
Recent activity
Exsiva Pharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Aminul Haque Choudhury was appointed as Director on 16 May 2016.
Charges
A charge with Uco Bank amounted to Rs. 100.00 Lakh with Charge ID 101193770 was registered on 28 Nov 2025.
AGM
Exsiva Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Exsiva Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Aminul Haque Choudhury was appointed as Director.
Appointed
Darpana Baruah was appointed as Director.
Incorporation
16 May 2016
Exsiva Pharma Private Limited was registered on 16 May 2016 with Roc Hyderabad & aged 10 years 5 months as per MCA records.
Frequently asked questions
Exsiva Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 May 2016 (10+ years old) and is registered under CIN U74999TG2016PTC126382.
Exsiva Pharma has 2 current directors:
- Darpana Baruah - Director
- Aminul Haque Choudhury - Director
The latest financial statements of Exsiva Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Exsiva Pharma is 18AAECE2652H1ZP, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Exsiva Pharma is U74999TG2016PTC126382. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exsiva Pharma was incorporated on 16 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Exsiva Pharma by revenue are HDJ Telecom Private Limited, Viraneka Enterprises Private Limited, Premium Air Care Solutions Private Limited, Kamalkant Vinimay Private Limited, R.R.R. Pharma Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Aminul Haque Choudhury was appointed as Director on 16 May 2016. Darpana Baruah was appointed as Director on 16 May 2016.
Yes, Exsiva Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0028070).
Exsiva Pharma can be reached through the website exsivapharma.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Exsiva Pharma is at No. 28 Pnr Meadows D. Pochampally Qutubullapur Mandal Hyderabad, Telangana, India – 500055.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages